Connor, Clark & Lunn Investment Management (CC&L)’s Utah Medical Products UTMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,603
| Closed | -$283K | – | 1621 |
|
|
2024
Q4 | $283K | Sell |
4,603
-5,734
| -55% | -$352K | ﹤0.01% | 1268 |
|
|
2024
Q3 | $692K | Buy |
10,337
+4,330
| +72% | +$290K | ﹤0.01% | 995 |
|
|
2024
Q2 | $401K | Buy |
6,007
+1,718
| +40% | +$115K | ﹤0.01% | 1107 |
|
|
2024
Q1 | $305K | Buy |
+4,289
| New | +$305K | ﹤0.01% | 1261 |
|